Independent
journalism that swims
against the current.
News
Health
Coronavirus

The Vancouver Company Turning Blood into a COVID Treatment: A Tyee Video

WATCH: Antibody therapy can help save lives. Here’s how it works.

Mashal Butt 1 Jul 2020TheTyee.ca

Mashal Butt is a graduate student at UBC’s School of Journalism, Writing and Media. She is completing a practicum at The Tyee. Follow her on Twitter @mashalbuttt.

The world anxiously awaits a vaccine to end the pandemic. But having a treatment could save countless lives in the meantime.

This Tyee video explains how Vancouver biotech company AbCellera, with funding from the federal government, is racing to develop an antibody-based therapy treatment as quickly as possible.

Experts — immunologist Ralph Pantophlet at Simon Fraser University, and co-founder and COO of AbCellera Véronique Lecault — explain what an antibody treatment is and how it can protect us from COVID-19.

With a vaccine likely a year or more away, this six-minute video explains how finding and isolating the right antibody from the blood of people who have recovered from COVID-19 could lead to a treatment that improves outcomes for people who are infected.

It is not a cure, but it can help save lives as we wait for the cure.

This video was made in partnership with Vancouver’s Avo Media team of Jesse Lupini, Koby Michaels and Lucas Kavanagh.  [Tyee]

Read more: Health, Coronavirus

  • Share:

Facts matter. Get The Tyee's in-depth journalism delivered to your inbox for free

Tyee Commenting Guidelines

Comments that violate guidelines risk being deleted, and violations may result in a temporary or permanent user ban. Maintain the spirit of good conversation to stay in the discussion.
*Please note The Tyee is not a forum for spreading misinformation about COVID-19, denying its existence or minimizing its risk to public health.

Do:

  • Be thoughtful about how your words may affect the communities you are addressing. Language matters
  • Challenge arguments, not commenters
  • Flag trolls and guideline violations
  • Treat all with respect and curiosity, learn from differences of opinion
  • Verify facts, debunk rumours, point out logical fallacies
  • Add context and background
  • Note typos and reporting blind spots
  • Stay on topic

Do not:

  • Use sexist, classist, racist, homophobic or transphobic language
  • Ridicule, misgender, bully, threaten, name call, troll or wish harm on others
  • Personally attack authors or contributors
  • Spread misinformation or perpetuate conspiracies
  • Libel, defame or publish falsehoods
  • Attempt to guess other commenters’ real-life identities
  • Post links without providing context

LATEST STORIES

The Barometer

Where Are You Feeling Inflation the Most?

Take this week's poll